Rapid disruption of gap junctional communication and phosphorylation of connexin43 by platelet-derived growth factor in T51B rat liver epithelial cells expressing platelet-derived growth factor receptor

✍ Scribed by Mohammad Z. Hossain; Peng Ao; Alton L. Boynton

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 349 KB
• Volume: 174
• Category: Article
• ISSN: 0021-9541
• DOI: 10.1002/(sici)1097-4652(199801)174:1<66::aid-jcp8>3.0.co;2-e

✦ Synopsis

Gap junctional communication (GJC) between contacting cells has been postulated to be involved in the regulation of cell proliferation. This suggestion stems from numerous studies showing modulation of GJC by agents that influence cellular proliferation. Platelet-derived growth factor (PDGF), a strong mitogen, inhibits GJC in many cell types. To understand the molecular nature of the signal transduction pathway responsible for the GJC blockade, T51B rat liver epithelial cells, which lack endogenous PDGF receptor (PDGFr), were infected with a retrovirus containing either wild-type full-length cDNA of human PDGFrb (Kin / ) or a mutant PDGFrb lacking receptor tyrosine kinase activity (Kin 0 ). PDGF caused a complete but transient interruption of cell communication in Kin / cells within 15-20 min of addition. This interruption of GJC was not associated with a gross destabilization of gap junction plaques but with the phosphorylation of connexin43 (Cx43), the only known gap junction protein expressed in these cells. These effects were not exhibited in either control T51B cells or in Kin 0 cells, indicating a requirement of the receptor tyrosine kinase activity. Further examination revealed that the newly phosphorylated Cx43 then undergoes a rapid degradation utilizing the lysosomal pathway resulting in a decreased total Cx43 protein level. The re-establishment of GJC following PDGF treatment was dependent on protein synthesis. This report describes a suitable cell system which is currently being utilized for the characterization of the PDGF signaling pathway responsible for the inhibition of GJC.